These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38792805)

  • 1. The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model.
    Xiong Y; Wang Z; Liu J; Li K; Zhang Y
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
    Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
    Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments.
    Qiao W; Xiong Y; Li K; Jin R; Zhang Y
    J Hepatocell Carcinoma; 2024; 11():1113-1125. PubMed ID: 38887683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model.
    Xiong Y; Qiao W; Mei T; Li K; Jin R; Zhang Y
    J Hepatocell Carcinoma; 2024; 11():1375-1388. PubMed ID: 39005969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
    Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
    Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.
    Zhang H; Sheng S; Qiao W; Sun Y; Jin R
    Front Oncol; 2024; 14():1395329. PubMed ID: 38800405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation.
    Qiao W; Li J; Wang Q; Jin R; Zhang H
    J Hepatocell Carcinoma; 2024; 11():271-284. PubMed ID: 38333222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
    Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
    J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation.
    Qiao W; Fan Z; Wang Q; Jin R; Hu C
    J Hepatocell Carcinoma; 2024; 11():65-79. PubMed ID: 38235069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nomogram based on the gamma-glutamyl transpeptidase-to-platelet ratio for patients with compensated cirrhotic hepatocellular carcinoma after local ablation.
    Qiao W; Li J; Wang P; Zhang Y; Jin R; Li J
    Front Oncol; 2024; 14():1406764. PubMed ID: 39055565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 14. Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection.
    Zhang ZJ; Wei BJ; Liu ZK; Xuan ZF; Zhou L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2024 Sep; ():. PubMed ID: 39332935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
    Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
    Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
    Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
    Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
    Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction and validation of a nomogram for hepatocellular carcinoma patients based on HCC-GRIm score.
    Yu X; Yang R; He Z; Li K; Zeng P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12013-12024. PubMed ID: 37421461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nomograms for HBV-related BCLC 0-a stage hepatocellular carcinoma incorporating aspartate aminotransferase to albumin ratio.
    Wu Y; Peng W; Shen J; Zhang X; Li C; Wen TF
    Scand J Gastroenterol; 2023 Jul; 58(7):789-797. PubMed ID: 36620916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta2-Microglobulin as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram.
    Lin Q; Jiang Z; Mo D; Liu F; Qin Y; Liang Y; Cheng Y; Huang H; Fang M
    J Hepatocell Carcinoma; 2023; 10():1813-1825. PubMed ID: 37850078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.